Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Dow
AstraZeneca
Johnson and Johnson
Merck

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Litigation Details for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. HETERO USA INC. (D.N.J. 2017)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. HETERO USA INC. (D.N.J. 2017)

Docket   Start Trial Date Filed 2017-10-05
Court District Court, D. New Jersey Date Terminated 2018-05-02
Cause 15:1126 Patent Infringement Assigned To Michael Andre Shipp
Jury Demand None Referred To Lois H. Goodman
Parties BOEHRINGER INGELHEIM INTERNATIONAL GMBH; BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG; BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.; HETERO LABS LIMITED; HETERO LABS LIMITED UNIT-V; HETERO USA INC.; PHV JEREMY D. COBB
Patents 8,426,586; RE43,431
Attorneys CHARLES MICHAEL LIZZA; DAVID C. KISTLER; DAVID LEIGH MOSES; SARAH ANN SULLIVAN; WILLIAM C. BATON
Firms Saul Ewing Arnstein & Lehr LLP
Link to Docket External link to docket
Small Molecule Drugs cited in BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. HETERO USA INC.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. HETERO USA INC. (D.N.J. 2017)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 United States Patent No. 8,426,586. A true and correct copy of United States Patent No. 8,426,586 is attached… infringement of United States Patent No. 8,426,586 (“the ’586 Patent”). This Court has jurisdiction … US 8,426,586 B2 Page 2 FOREIGN PATENT DOCUMENTS…PageID: 16 US. Patent Apr. 23, 2013 Sheet 1 of2 US 8,426,586 B2 … US 8,426,586 B2 Soyka et a]. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Harvard Business School
Moodys
Dow
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.